Search
Search Constraints
You searched for: Author/Creator Hiley, Crispin T.Limit your search
- 616.9940642 1
- ATM Ataxia telangiectasia mutated -- ATR Ataxia telangiectasia and Rad3 related -- cfDNA Cell-free DNA -- CRT Chemoradiotherapy -- CT Computed tomography -- CTCAE Common terminology criteria for adverse events -- CTRad Clinical and Translational Radiotherapy Research Working Group -- DDRi DNA damage response inhibitor -- DLT Dose limiting toxicity -- DNA Deoxyribonucleic acid -- DNA-PK DNA-dependent protein kinase -- ECOG Eastern Cooperative Oncology Group -- EORTC European Organisation for Research and Treatment of Cancer -- ICRU International Commission on Radiation Units and Measurements -- IMPs Investigational medicinal products -- LA Locally advanced -- MRC Medical Research Council -- NCRI National Cancer Research Institute -- NSCLC Non-small cell lung cancer -- PARP Poly (ADP-ribose) polymerase -- PET Positron emission tomography -- PFS Progression free survival -- PROMs Patient-reported outcome measures -- RECIST Response evaluation criteria in solid tumours -- RP2D Recommended phase II dose -- RT Radiotherapy -- SACT Systemic anti-cancer therapy -- SRC Safety review committee -- TiTE-CRM Time to event continual reassessment method -- TNM Tumour node metastasis 1
- Cancer -- Radiotherapy 1
- Cancer -- Radiotherapy -- Periodicals 1
- Electronic journals 1
- Neoplasms -- radiotherapy 1
- Non-small cell lung cancer -- Sequential chemoradiotherapy -- DNA damage repair inhibitor -- Platform trial -- Continual reassessment method 1
- Oncology 1
- Oncology -- Periodicals 1
- Periodicals 1